Promising early-phase trial results for a new disease-modifying therapy in ALS. Hope is tempered by the need for larger confirmatory studies. - http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332014000100004 , Genetic testing for hereditary cancer syndromes should be offered more broadly based on family history. .